The goal of this program is to leverage the clinical and basic research expertise and resources available at Northwestern University to train MD and MD/PhD fellows in infectious disease translational research. This training program will build on the Infectious Diseases Fellowship Program, which attracts top-notch physician-scientists. The clinical expertise of the Infectious Disease Division together with the long-standing basic science strengths in microbiology and immunology at Northwestern University have created a rich environment for translational research. The proposed training program will serve as a nidus of collaboration between these two groups. Each trainee will work with both a primary research mentor and a clinical co-mentor, which will foster interaction between research and clinical faculty and enhance the translational aspects of the fellow's research experience. A training program consisting of a Master's of Science in Clinical Investigation degree, seminars, career development programs, and education in the ethical conduct of research has been developed to promote excellence in research. We propose to fund one highly qualified MD or MD/PhD fellow per year for a two-year intensive research experience. Furthermore, the Northwestern University Department of Medicine has committed to match this award should it be funded, such that resources will be available for a total of two trainees per year to complete two years in the program. Together, these activities will enable trainees to obtain funding and develop into independent researchers.
The continued emergence of new pathogens, the unacceptable morbidity and mortality due to conventional infections, and the epidemics of antibiotic-resistant bacteria highlight the need for well-trained researchers in infectious disease. This postgraduate training program in infectious diseases will provide training for investigators capable of harnessing the discoveries in the basic sciences of microbiology and immunology to develop novel interventions aimed at ameliorating the burden of infectious diseases.
|Krapp, Fiorella; Ozer, Egon A; Qi, Chao et al. (2018) Case Report of an Extensively Drug-Resistant Klebsiella pneumoniae Infection With Genomic Characterization of the Strain and Review of Similar Cases in the United States. Open Forum Infect Dis 5:ofy074|
|Trinh, Sonya A; Angarone, Michael P (2017) Purpureocillium lilacinum tattoo-related skin infection in a kidney transplant recipient. Transpl Infect Dis 19:|
|Krapp, Fiorella; Morris, Andrew R; Ozer, Egon A et al. (2017) Virulence Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Strains from Patients with Necrotizing Skin and Soft Tissue Infections. Sci Rep 7:13533|
|Trinh, Sonya A; Echenique, Ignacio A; Penugonda, Sudhir et al. (2017) Optimal strategies for the diagnosis of community-onset diarrhea in solid organ transplant recipients: Less is more. Transpl Infect Dis 19:|
|Fitzpatrick, Margaret A; Ozer, Egon A; Hauser, Alan R (2016) Utility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital Outbreaks. J Clin Microbiol 54:593-612|
|Ozer, Egon A; Morris, Andrew R; Krapp, Fiorella et al. (2016) Draft Genome Sequence of a Multidrug-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Isolate from a Clinical Source. Genome Announc 4:|
|Fitzpatrick, Margaret A; Ozer, Egon; Bolon, Maureen K et al. (2015) Influence of ACB complex genospecies on clinical outcomes in a U.S. hospital with high rates of multidrug resistance. J Infect 70:144-52|
|Walker, Ellie; Ison, Michael G (2014) Respiratory viral infections among hospitalized adults: experience of a single tertiary healthcare hospital. Influenza Other Respir Viruses 8:282-92|
|Fitzpatrick, Margaret; Zembower, Teresa; Malczynski, Michael et al. (2014) Outcomes of an enhanced surveillance program for carbapenem-resistant Enterobacteriaceae. Infect Control Hosp Epidemiol 35:419-22|
|Ozer, Egon A; Fitzpatrick, Margaret A; Hauser, Alan R (2014) Draft Genome Sequence of Acinetobacter baumannii Strain ABBL099, a Multidrug-Resistant Clinical Outbreak Isolate with a Novel Multilocus Sequence Type. Genome Announc 2:|